TY - JOUR AU - Anderson, B. O. AU - Yip, C. H. AU - Smith, R. A. AU - Shyyan, R. AU - Sener, S. F. AU - Eniu, A. PY - 2008 DA - 2008// TI - Guideline implementation for breast healthcare in low-income and middle-income countries: overview of the breast health global initiative global summit 2007 JO - Cancer. VL - 113 UR - https://doi.org/10.1002/cncr.23844 DO - 10.1002/cncr.23844 ID - Anderson2008 ER - TY - JOUR AU - Bauer, K. R. AU - Brown, M. AU - Cress, R. D. AU - Parise, C. A. AU - Caggiano, V. PY - 2007 DA - 2007// TI - Descriptive analysis of estrogen receptor (ER)-negative, progesterone receptor (PR)-negative, and HER2-negative invasive breast cancer, the so-called triple-negative phenotype JO - Cancer. VL - 109 UR - https://doi.org/10.1002/cncr.22618 DO - 10.1002/cncr.22618 ID - Bauer2007 ER - TY - JOUR AU - Anders, C. K. AU - Carey, L. A. PY - 2009 DA - 2009// TI - Biology metastatic patterns and treatment of patients with triple-negative breast cancer JO - Clin Breast Cancer VL - 9 UR - https://doi.org/10.3816/CBC.2009.s.008 DO - 10.3816/CBC.2009.s.008 ID - Anders2009 ER - TY - JOUR AU - Reis-Filho, J. S. AU - Tutt, A. N. PY - 2008 DA - 2008// TI - Triple negative tumours: a critical review JO - Histopathology. VL - 52 UR - https://doi.org/10.1111/j.1365-2559.2007.02889.x DO - 10.1111/j.1365-2559.2007.02889.x ID - Reis-Filho2008 ER - TY - JOUR AU - Jeruss, J. S. AU - Mittendorf, E. A. AU - Tucker, S. L. AU - Gonzalez-Angulo, A. M. AU - Buchholz, T. A. AU - Sahin, A. A. PY - 2008 DA - 2008// TI - Combined use of clinical and pathologic staging variables to define outcomes for breast cancer patients treated with neoadjuvant therapy JO - J Clin Oncol VL - 26 UR - https://doi.org/10.1200/JCO.2007.11.5352 DO - 10.1200/JCO.2007.11.5352 ID - Jeruss2008 ER - TY - JOUR AU - Kuerer, H. M. AU - Newman, L. A. AU - Smith, T. L. AU - Ames, F. C. AU - Hunt, K. K. AU - Dhingra, K. PY - 1999 DA - 1999// TI - Clinical course of breast cancer patients with complete pathological primary tumor and axillary lymph node response to doxorubicin-based neoadjuvant chemotherapy JO - J Clin Oncol VL - 17 UR - https://doi.org/10.1200/JCO.1999.17.2.460 DO - 10.1200/JCO.1999.17.2.460 ID - Kuerer1999 ER - TY - JOUR AU - Liedtke, C. AU - Mazouni, C. AU - Hess, K. R. AU - André, F. AU - Tordai, A. AU - Mejia, J. A. PY - 2008 DA - 2008// TI - Response to neoadjuvant therapy and long-term survival in patients with triple-negative breast cancer JO - J Clin Oncol VL - 26 UR - https://doi.org/10.1200/JCO.2007.14.4147 DO - 10.1200/JCO.2007.14.4147 ID - Liedtke2008 ER - TY - JOUR AU - Huober, J. AU - Minckwitz, G. AU - Denkert, C. AU - Tesch, H. AU - Weiss, E. AU - Zahm, D. M. PY - 2010 DA - 2010// TI - Effect of neoadjuvant anthracycline-taxane-based chemotherapy in different biological breast cancer phenotypes: overall results from the GeparTrio study JO - Breast Cancer Res Treat VL - 124 UR - https://doi.org/10.1007/s10549-010-1103-9 DO - 10.1007/s10549-010-1103-9 ID - Huober2010 ER - TY - JOUR AU - Carey, L. A. AU - Dees, E. C. AU - Sawyer, L. AU - Gatti, L. AU - Moore, D. T. AU - Collichio, F. PY - 2007 DA - 2007// TI - The triple negative paradox: primary tumor chemosensitivity of breast cancer subtypes JO - Clin Cancer Res VL - 13 UR - https://doi.org/10.1158/1078-0432.CCR-06-1109 DO - 10.1158/1078-0432.CCR-06-1109 ID - Carey2007 ER - TY - JOUR AU - Rouzier, R. AU - Perou, C. M. AU - Symmans, W. F. AU - Ibrahim, N. AU - Cristofanilli, M. AU - Anderson, K. PY - 2005 DA - 2005// TI - Breast cancer molecular subtypes respond differently to preoperative chemotherapy JO - Clin Cancer Res VL - 11 UR - https://doi.org/10.1158/1078-0432.CCR-04-2421 DO - 10.1158/1078-0432.CCR-04-2421 ID - Rouzier2005 ER - TY - JOUR AU - Ring, A. E. AU - Smith, I. E. AU - Ashley, S. AU - Fulford, L. G. AU - Lakhani, S. R. PY - 2004 DA - 2004// TI - Lakhani Oestrogen receptor status, pathological complete response and prognosis in patients receiving neoadjuvant chemotherapy for early stage breast cancer JO - Br J Cancer VL - 91 UR - https://doi.org/10.1038/sj.bjc.6602235 DO - 10.1038/sj.bjc.6602235 ID - Ring2004 ER - TY - JOUR AU - Clifton, K. AU - Gutierrez-Barrera, A. AU - Ma, J. AU - Bassett, R. AU - Litton, J. AU - Kuerer, H. PY - 2018 DA - 2018// TI - Adjuvant versus neoadjuvant chemotherapy in triple-negative breast cancer patients with BRCA mutations JO - Breast Cancer Res Treat VL - 170 UR - https://doi.org/10.1007/s10549-018-4727-9 DO - 10.1007/s10549-018-4727-9 ID - Clifton2018 ER - TY - JOUR AU - Fisher, C. S. AU - Ma, C. X. AU - William, E. AU - Aft, R. L. AU - Eberlein, T. J. AU - Gao, F. PY - 2012 DA - 2012// TI - Neoadjuvant chemotherapy is associated with improved survival compared with adjuvant chemotherapy in patients with triple-negative breast cancer only after complete pathologic response JO - Ann Surg Oncol VL - 19 UR - https://doi.org/10.1245/s10434-011-1877-y DO - 10.1245/s10434-011-1877-y ID - Fisher2012 ER - TY - JOUR AU - Carlie, R. PY - 2010 DA - 2010// TI - Kennedy, Feng Gao, Julie a Margenthaler. Neoadjuvant versus adjuvant chemotherapy for triple negative breast cancer JO - J Surg Res VL - 163 UR - https://doi.org/10.1016/j.jss.2010.04.015 DO - 10.1016/j.jss.2010.04.015 ID - Carlie2010 ER - TY - JOUR AU - Sharma, P. AU - Kimler, B. F. AU - Klemp, J. R. AU - CS, C. PY - 2015 DA - 2015// TI - Outcomes with neoadjuvant versus adjuvant chemotherapy for T1-2 node negative triple negative breast cancer JO - J Clin Oncol VL - 33 ID - Sharma2015 ER - TY - JOUR AU - Cheng, Y. C. AU - Smith, E. AU - Yen, T. PY - 2017 DA - 2017// TI - Abstract P5-16-09: overall survival of patients with non-metastatic triple negative breast cancer who received neoadjuvant vs adjuvant chemotherapy: cohort analysis of National Cancer Data Base (NCDB) 2010–2011 JO - Cancer Res VL - 77 UR - https://doi.org/10.1158/0008-5472.CAN-17-0313 DO - 10.1158/0008-5472.CAN-17-0313 ID - Cheng2017 ER - TY - JOUR AU - Yang, H. AU - Zhou, L. AU - Wang, S. AU - Cao, Y. AU - Tong, F. AU - Liu, P. PY - 2018 DA - 2018// TI - Retrospective analysis of concurrent docetaxel and epirubicin neoadjuvant versus adjuvant chemotherapy: which leads to better outcomes for different subtype breast cancer patients? JO - Medicine VL - 97 ID - Yang2018 ER - TY - JOUR AU - Biswas, T. AU - Jimmy, T. PY - 2017 DA - 2017// TI - Efird, Prasad S, Jindal C, Paul R. the survival benefit of neoadjuvant chemotherapy and pCR among patients with advanced stage triple negative breast cancer JO - Oncotarget. VL - 8 UR - https://doi.org/10.18632/oncotarget.22521 DO - 10.18632/oncotarget.22521 ID - Biswas2017 ER - TY - JOUR AU - Bagegni, N. A. AU - Tao, Y. AU - Ademuyiwa, F. O. PY - 2019 DA - 2019// TI - Clinical outcomes with neoadjuvant versus adjuvant chemotherapy for triple negative breast cancer: a report from the National Cancer Database JO - PLoS One VL - 14 UR - https://doi.org/10.1371/journal.pone.0222358 DO - 10.1371/journal.pone.0222358 ID - Bagegni2019 ER - TY - JOUR AU - Philipovskiy, A. AU - Corral, J. AU - Dwivedi, K. A. AU - Heydarian, R. AU - Gaur, S. PY - 2019 DA - 2019// TI - Efficacy of neoadjuvant versus adjuvant chemotherapy in Hispanic/Latino H/L women with local or locally advanced triple-negative breast cancer(TNBC) JO - In Vivo VL - 33 UR - https://doi.org/10.21873/invivo.11594 DO - 10.21873/invivo.11594 ID - Philipovskiy2019 ER - TY - JOUR AU - Stang, A. PY - 2010 DA - 2010// TI - Critical evaluation of the Newcastle-Ottawa scale for the assessment of the quality of nonrandomized studies in meta-analyses JO - Eur J Epidemiol VL - 25 UR - https://doi.org/10.1007/s10654-010-9491-z DO - 10.1007/s10654-010-9491-z ID - Stang2010 ER - TY - JOUR AU - Tierney, J. F. AU - Stewart, L. A. AU - Ghersi, D. AU - Burdett, S. AU - Sydes, M. R. PY - 2007 DA - 2007// TI - Practical methods for incorporating summary time-to-event data into meta-analysis JO - Trials. VL - 8 UR - https://doi.org/10.1186/1745-6215-8-16 DO - 10.1186/1745-6215-8-16 ID - Tierney2007 ER - TY - JOUR AU - Egger, M. AU - Smith, G. D. AU - Schneider, M. PY - 1997 DA - 1997// TI - Bias in meta-analysis detected by a simple, graphical test JO - BMJ. VL - 315 UR - https://doi.org/10.1136/bmj.315.7109.629 DO - 10.1136/bmj.315.7109.629 ID - Egger1997 ER - TY - JOUR AU - Wolmark, N. AU - Wang, J. AU - Mamounas, E. AU - Bryant, J. AU - Fisher, B. PY - 2001 DA - 2001// TI - Preoperative chemotherapy in patients with operable breast cancer: nine-year results from national surgical adjuvant breast and bowel project B-18 JO - Monogr Natl Cancer Inst VL - 30 UR - https://doi.org/10.1093/oxfordjournals.jncimonographs.a003469 DO - 10.1093/oxfordjournals.jncimonographs.a003469 ID - Wolmark2001 ER - TY - JOUR AU - Hage, J. A. AU - Velde, C. J. AU - Julien, J. P. AU - Tubiana-Hulin, M. AU - Vandervelden, C. AU - Duchateau, L. PY - 2001 DA - 2001// TI - Preoperative chemotherapy in primary operable breast cancer: results from the European Organization for Research and Treatment of cancer trial 10902 JO - J Clin Oncol VL - 19 UR - https://doi.org/10.1200/JCO.2001.19.22.4224 DO - 10.1200/JCO.2001.19.22.4224 ID - Hage2001 ER - TY - JOUR AU - Mauriac, L. AU - MacGrogan, G. AU - Avril, A. AU - Durand, M. AU - Floquet, A. AU - Debled, M. PY - 1999 DA - 1999// TI - Neoadjuvant chemotherapy for operable breast carcinoma larger than 3 cm: a unicentre randomized trial with a 124-month median follow-up JO - Ann Oncol VL - 10 UR - https://doi.org/10.1023/A:1008337009350 DO - 10.1023/A:1008337009350 ID - Mauriac1999 ER - TY - JOUR AU - Lin, N. U. AU - Claus, E. AU - Sohl, J. AU - Razzak, A. R. AU - Arnaout, A. AU - Winer, E. P. PY - 2008 DA - 2008// TI - Sites of distant recurrence and clinical outcomes in patients with metastatic triple-negative breast cancer JO - Cancer. VL - 113 UR - https://doi.org/10.1002/cncr.23930 DO - 10.1002/cncr.23930 ID - Lin2008 ER - TY - JOUR AU - Dawood, S. AU - Broglio, K. AU - Esteva, F. J. AU - Yang, W. AU - Kau, S. W. AU - Islam, R. PY - 2009 DA - 2009// TI - Survival among women with triple receptor-negative breast cancer and brain metastases JO - Ann Oncol VL - 20 UR - https://doi.org/10.1093/annonc/mdn682 DO - 10.1093/annonc/mdn682 ID - Dawood2009 ER - TY - JOUR AU - Haque, W. AU - Verma, V. AU - Hatch, S. AU - Suzanne Klimberg, V. AU - Brian Butler, E. AU - Teh, B. S. PY - 2018 DA - 2018// TI - Response rates and pathologic complete response by breast cancer molecular subtype following neoadjuvant chemotherapy JO - Breast Cancer Res Treat VL - 170 UR - https://doi.org/10.1007/s10549-018-4801-3 DO - 10.1007/s10549-018-4801-3 ID - Haque2018 ER - TY - JOUR PY - 2018 DA - 2018// TI - Long-term outcomes for neoadjuvant versus adjuvant chemotherapy in early breast cancer: meta-analysis of individual patient data from ten randomised trials JO - Lancet Oncol VL - 19 UR - https://doi.org/10.1016/S1470-2045(17)30777-5 DO - 10.1016/S1470-2045(17)30777-5 ID - ref30 ER - TY - JOUR AU - Mauri, D. AU - Pavlidis, N. AU - Ioannidis, J. P. PY - 2005 DA - 2005// TI - Neoadjuvant versus adjuvant systemic treatment in breast cancer: a meta-analysis JO - J Natl Cancer Inst VL - 97 UR - https://doi.org/10.1093/jnci/dji021 DO - 10.1093/jnci/dji021 ID - Mauri2005 ER - TY - JOUR AU - Baron, L. F. AU - Baron, P. L. AU - Ackerman, S. J. AU - Durden, D. D. AU - Pope, T. L. PY - 2000 DA - 2000// TI - Sonographically guided clip placement facilitates localization of breast cancer after neoadjuvant chemotherapy JO - AJR Am J Roentgenol VL - 174 UR - https://doi.org/10.2214/ajr.174.2.1740539 DO - 10.2214/ajr.174.2.1740539 ID - Baron2000 ER - TY - JOUR AU - Minckwitz, G. AU - Untch, M. AU - Blohmer, J. U. AU - Costa, S. D. AU - Eidtmann, H. AU - Fasching, P. A. PY - 2012 DA - 2012// TI - Definition and impact of pathologic complete response on prognosis after neoadjuvant chemotherapy in various intrinsic breast cancer subtypes JO - J Clin Oncol VL - 30 UR - https://doi.org/10.1200/JCO.2011.38.8595 DO - 10.1200/JCO.2011.38.8595 ID - Minckwitz2012 ER -